Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab and chemotherapy for prostate cancer that has spread (KEYNOTE 921)

Overview

Cancer types:

Prostate cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for men who have prostate cancer that has spread elsewhere in the body despite hormone treatment.

Prostate cancer that has spread to other parts of the body is advanced or metastatic cancer.

Recruitment start: 28 September 2019

Recruitment end: 14 June 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann de Bono

Supported by

Merck Sharp & Dohme LLC

Last reviewed: 21 Jun 2021

CRUK internal database number: 17101

Help and support